The authors explain the benefits of ACE-inhibitors in controlling the progression of renal disease.
You are here
P&T® Journal contents for February 2003
A family practitioner discovers some of the lessons to be learned from treating a terminally ill patient.
The author reviews ezetimibe for lowering blood lipid levels, atomoxetine for attention-deficit hyperactivity disorder, and injectable teriparatide for osteoporosis.
Letter to the Editor
Drug companies can satisfy their customers by responding to their increasing demands for information.
The authors discuss a new topical therapeutic agent for the treatment of genital warts and other skin conditions.